Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have... CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today ...

Morgan Stanley analyst Erin Wright maintained a Hold rating on Cencora (COR – Research Report) today and set a price target of $263.00. The company’s shares closed yesterday at $254.89.

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 ...

The latest sale netted about $300 million for Walgreens, and shrinks the company’s stake in Cencora to approximately 6%, down from 10%, according to a press release on Thursday. Walgreens said ...

Cherny now forecasts that the company will earn $4.08 per share for the quarter, down from their prior forecast of $4.23. The consensus estimate for Cencora’s current full-year earnings is $15. ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Discover why a logo is important for your business branding. Get help from a creative logo design agency for impressive results. A company's logo is one of its most valuable assets. More than just a ...

we can get a feel for how investor attitudes to a company have morphed over time. During five years of share price growth, Cencora achieved compound earnings per share (EPS) growth of 18% per year.

We believe Cencora is well positioned to enjoy these dynamics and expect it to maintain a leading position over our forecast period. The company has partnerships with some of the biggest customers ...